A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis
Clinical trial NCT04152226 · COMPLETED
Trial details
- NCT number
- NCT04152226
- Sponsor
- DermBiont, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2019-04-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.